DROSPIRENONE AND ETHINYL ESTRADIOL-  drospirenone and ethinyl estradiol  kit United States - English - NLM (National Library of Medicine)

drospirenone and ethinyl estradiol- drospirenone and ethinyl estradiol kit

nivagen pharmaceuticals, inc. - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone and ethinyl estradiol tablets are indicated for use by women to prevent pregnancy. drospirenone and ethinyl estradiol tablets are also indicated for the treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who choose to use an oral contraceptive as their method of contraception. the effectiveness of drospirenone and ethinyl estradiol tablets for pmdd when used for more than three menstrual cycles has not been evaluated. the essential features of pmdd according to the diagnostic and statistical manual-4th edition (dsm-iv) include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. physical symptoms associated with pmdd include breast tenderness, headache, joint and muscle pain, bloating and weight gain. in this disorder, these symptoms occur regularly during the luteal

BROOKLYNN drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack Australia - English - Department of Health (Therapeutic Goods Administration)

brooklynn drospirenone/ethinyloestradiol 3 mg/30 microgram tablet blister composite pack

alphapharm pty ltd - drospirenone, quantity: 3 mg; ethinylestradiol, quantity: 0.03 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; polacrilin potassium - drospirenone/ethinyloestradiol-alphapharm 3/30 is indicated for use as an oral contraceptive.

ETHINYLESTRADIOL/DROSPIRENONE LEON FARMA & PLACEBO Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo

laboratorios leon farma, s.a. - drospirenone ethinylestradiol - film coated tablet - 0.03 / 3 milligram

ETHINYLESTRADIOL/DROSPIRENONE LEON FARMA & PLACEBO Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo

laboratorios leon farma, s.a. - drospirenone ethinylestradiol - film coated tablet - 0.02 / 3 milligram

ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma

rowex ltd - drospirenone ethinylestradiol - film coated tablet - 0.03 / 3 milligram

YASMIN Israel - English - Ministry of Health

yasmin

bayer israel ltd - drospirenone; ethinylestradiol - film coated tablets - drospirenone 3 mg; ethinylestradiol 0.03 mg - drospirenone and estrogen - drospirenone and estrogen - oral contraception.

ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma

laboratorios leon farma, s.a. - drospirenone ethinylestradiol - film coated tablet - 0.02 / 3 milligram

ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma

laboratorios leon farma, s.a. - drospirenone ethinylestradiol - film coated tablet - 0.03 / 3 milligram

ETHINYLESTRADIOL / DROSPIRENONE LEON FARMA & PLACE Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol / drospirenone leon farma & place

rowex ltd - drospirenone ethinylestradiol - film coated tablet - 0.03 / 3 milligram